Wrap-Up of US Chemical Regulatory Developments, July 2018

The website JD Supra has published a collection of regulatory updates provided by the law firm Bergeson & Campbell, P.C.. Here an overview of the information you can find on that webpage:

(*) TSCA At 2: An Update On Implementation And Hot Topics

(*) EPA Issues Final Rule Delaying Compliance Date For Human Subjects Policy By Six Months

(*) EPA Issues Final Guidance On Points To Consider When Preparing TSCA New Chemical Notifications

(*) EPA Discusses APEP For Products With Public Health Claims In The Marketplace

(*) EPA Issues Guidance On Creating Generic Names For Confidential Chemical Substance Identity Reporting Under TSCA

(*) EPA Celebrates Anniversary Of Lautenberg Act By Releasing Final CBI Guidance, Animal Testing Strategy, And Final Mercury Reporting Rule

(*) EPA Releases Final Strategic Plan To Promote The Development And Implementation Of Alternative Test Methods Within The TSCA Program

(*) EPA Holds Preparatory Meeting For Experts Selected To Serve As Letter Peer Reviewers

(*) EPA Proposes To Lower Dust- lead Hazard Standards

(*) EPA Extends Comment Period For Review Of SO_X NAAQS

(*) EPA Decides It Will Not Amend SPCC Program’s Scope To Include Hazardous Substances

(*) EPA Issues Final Rule Extending Reporting Period Under Mercury And Air Toxics Standards

(*) EPA To Hold Public Hearing For The Renewable Fuel Standard Program

(*) EPA Extends Comment Period On Its Cost-And-Benefit Transparency ANPRM

(*) EPA Clarifies “Waters Of The U.S.” Rescission With Supplemental Notice

(*) FDA Announces Draft Guidance On Mitigation Strategies To Protect Food Against Intentional Adulteration

(*) White House Announces Plan To Consolidate Federal Food Safety Under One Agency

(*) FDA Announces Public Meeting On Comprehensive, Multi-Year Nutrition Innovation Strategy

(*) FDA Issues Guidance To Help Animal Drug Manufacturers Meet Antimicrobial Sales Dat Reporting Requirements

(*) FDA Issues Draft Guidance Providing Recommendations On Human Drug And Biological Product Labeling

(*) FDA Announces Cooperative Agreements In Support Of Efforts To Implement FSMA

CONTINUE READING ON www.jdsupra.com